Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Part B Demo Coverage Should Be Broad, Senate Staffer Tells CMS

Executive Summary

Senate drafters of the Medicare Rx law intended the Part B "replacement" drug demonstration project to include oral drugs that do not replace an injectable product, a staffer for Sen. Olympia Snowe (R-Maine) told the Centers for Medicare & Medicaid Services
Advertisement

Related Content

Medicare Part B Oral Chemotherapy Demo Limited To Approved Indications
Medicare Part B Oral Chemotherapy Demo Limited To Approved Indications
Medicare Part B Demonstration Project Will Be Set In “Weeks” – CMS
Advertisement
UsernamePublicRestriction

Register

PS043874

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel